Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
CEN Case Rep ; 10(1): 46-52, 2021 02.
Artigo em Inglês | MEDLINE | ID: mdl-32754805

RESUMO

Both the diagnosis of elderly-onset IgA vasculitis (IgAV) and its prognosis can be difficult because of its rarity and the likely presence of comorbidities. Furthermore, the treatment of elderly-onset IgAV remains controversial: the ideal dosages of corticosteroid and/or immunosuppressants have not been determined. In the elderly, corticosteroid adverse effects can lead to severe outcomes, and a consensus regarding its benefit and risk balance has not been reached. We report a case of IgAV in an 89-year-old patient who was admitted to our hospital to investigate a 30-day history of palpable purpura and pitting edema on her leg. A renal biopsy showed membranoproliferative glomerulonephritis with IgA deposits (The International Study of Kidney Disease in Children (ISKDC) grade VI), which is a predictor of a poor prognosis; these findings led to early intervention with low-dose corticosteroid (15 mg/day) and mizoribine. As a result, a complete remission without obvious adverse effects was obtained. Early intervention with low-dose corticosteroid and mizoribine based on renal histopathology results might be an effective treatment for elderly-onset ISKDC grade VI IgAV.


Assuntos
Corticosteroides/uso terapêutico , Glomerulonefrite Membranoproliferativa/patologia , Imunoglobulina A/imunologia , Ribonucleosídeos/uso terapêutico , Vasculite/tratamento farmacológico , Vasculite/imunologia , Corticosteroides/administração & dosagem , Idoso de 80 Anos ou mais , Biópsia , Comorbidade , Quimioterapia Combinada , Edema/diagnóstico , Edema/etiologia , Feminino , Glomerulonefrite Membranoproliferativa/diagnóstico , Glomerulonefrite Membranoproliferativa/imunologia , Humanos , Vasculite por IgA/diagnóstico , Vasculite por IgA/etiologia , Imunossupressores/administração & dosagem , Imunossupressores/uso terapêutico , Rim/patologia , Perna (Membro)/patologia , Síndrome Nefrótica/diagnóstico , Síndrome Nefrótica/etiologia , Indução de Remissão , Ribonucleosídeos/administração & dosagem , Vasculite/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA